Professor Emeritus, School of Health Policy and Management, York University, Associate Professor, Faculty of Medicine, University of Toronto, Toronto, ON.
Healthc Policy. 2024 Aug;19(4):70-80. doi: 10.12927/hcpol.2024.27349.
Medical school deans wield considerable influence over research, clinical and educational missions at their institutions. This study investigates conflict of interest (COI) of Canadian medical school deans.
The websites of all 17 Canadian medical schools were searched for any mention of relationships between deans and pharmaceutical or medical device companies.
No COIs were discovered for 11 of the deans. Six had COIs, including participating in research funded by pharmaceutical companies and received consulting and speaker fees.
A minority of deans had COIs with healthcare industry companies. Whether deans' COIs affect policies at the medical schools they lead should be the subject of further investigation.
医学院院长对其所在机构的研究、临床和教育任务具有相当大的影响力。本研究调查了加拿大医学院院长的利益冲突(COI)。
搜索了所有 17 所加拿大医学院的网站,以查找院长与制药公司或医疗器械公司之间关系的任何提及。
11 位院长没有发现利益冲突。六位院长存在利益冲突,包括参与制药公司资助的研究以及收取咨询费和演讲费。
少数院长与医疗保健行业公司存在利益冲突。院长的利益冲突是否会影响他们领导的医学院的政策,这应该是进一步调查的主题。